118 related articles for article (PubMed ID: 26609651)
1. COX-2 gene variants in bipolar disorder-I.
Ozdemircan A; Dasdemir S; Kucukali CI; Bireller ES; Ozturk H; Cakmakoglu B
Psychiatr Danub; 2015 Dec; 27(4):385-9. PubMed ID: 26609651
[TBL] [Abstract][Full Text] [Related]
2. Cox-2 gene variants in migraine.
Dasdemir S; Cetinkaya Y; Gencer M; Ozkok E; Aydin M; Cakmakoglu B
Gene; 2013 Apr; 518(2):292-5. PubMed ID: 23357220
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 gene and lung carcinoma risk.
Coskunpinar E; Eraltan IY; Turna A; Agachan B
Med Oncol; 2011 Dec; 28(4):1436-40. PubMed ID: 20645029
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 Gene Polymorphisms -765G>C and -1195A>G and Mycosis Fungoides Risk.
Sayed KS; Mohammed FN; Abdel Hay RM; Amr KS; AlOrbani AM
Dermatology; 2021; 237(1):17-21. PubMed ID: 31846957
[TBL] [Abstract][Full Text] [Related]
5. COX-2 polymorphisms -765G-->C and -1195A-->G and colorectal cancer risk.
Hoff JH; te Morsche RH; Roelofs HM; van der Logt EM; Nagengast FM; Peters WH
World J Gastroenterol; 2009 Sep; 15(36):4561-5. PubMed ID: 19777615
[TBL] [Abstract][Full Text] [Related]
6. Functional polymorphisms of cyclooxygenase-2 gene and risk for hepatocellular carcinoma.
Akkız H; Bayram S; Bekar A; Akgöllü E; Ülger Y
Mol Cell Biochem; 2011 Jan; 347(1-2):201-8. PubMed ID: 21042835
[TBL] [Abstract][Full Text] [Related]
7. COX-2 polymorphisms -765G→C and -1195A→G and hepatocellular carcinoma risk.
Gharib AF; Karam RA; Abd El Rahman TM; Elsawy WH
Gene; 2014 Jun; 543(2):234-6. PubMed ID: 24720952
[TBL] [Abstract][Full Text] [Related]
8. -765 G→C and -1195 A→G promoter variants of the cyclooxygenase-2 gene decrease the risk for preeclampsia.
Gurdol F; Cakmakoglu B; Dasdemir S; Isbilen E; Bekpinar S; Isbir T
Genet Test Mol Biomarkers; 2012 May; 16(5):435-8. PubMed ID: 22224631
[TBL] [Abstract][Full Text] [Related]
9. Association of functional gene variants in the regulatory regions of COX-2 gene (PTGS2) with nonmelanoma skin cancer after organ transplantation.
Lira MG; Mazzola S; Tessari G; Malerba G; Ortombina M; Naldi L; Remuzzi G; Boschiero L; Forni A; Rugiu C; Piaserico S; Girolomoni G; Turco A
Br J Dermatol; 2007 Jul; 157(1):49-57. PubMed ID: 17578436
[TBL] [Abstract][Full Text] [Related]
10. [Association between single nucleotide polymorphisms in the promoter of cyclooxygenase COX-2 gene and hereditary susceptibility to pancreatic cancer].
Xu DK; Zhang XM; Zhao P; Cai JC; Zhao D; Tan W; Guo YL; Lin DX
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1961-5. PubMed ID: 19062735
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of paraoxonase 1 polymorphisms in patients with bipolar disorder.
Küçükali CI; Ulusoy C; Özkan Ö; Orhan N; Güleç H; Erdağ E; Buker S; Tüzün E
In Vivo; 2015; 29(1):103-8. PubMed ID: 25600537
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 gene and epithelial ovarian carcinoma risk.
Agachan Cakmakoglu B; Attar R; Kahraman OT; Dalan AB; Iyibozkurt AC; Karateke A; Attar E
Mol Biol Rep; 2011 Jun; 38(5):3481-6. PubMed ID: 21107726
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between single nucleotide polymorphisms in the promoter of COX-2 gene and hereditariness to NAFLD].
Cao MB; Yang YX; Dong L
Zhonghua Gan Zang Bing Za Zhi; 2010 Oct; 18(10):773-7. PubMed ID: 21059296
[TBL] [Abstract][Full Text] [Related]
14. Association of
Mozaffari E; Doosti A; Arshi A; Faghani M
Iran J Public Health; 2016 Dec; 45(12):1625-1635. PubMed ID: 28053929
[TBL] [Abstract][Full Text] [Related]
15. Further support for association of the mitochondrial complex I subunit gene NDUFV2 with bipolar disorder.
Xu C; Li PP; Kennedy JL; Green M; Hughes B; Cooke RG; Parikh SV; Warsh JJ
Bipolar Disord; 2008 Feb; 10(1):105-10. PubMed ID: 18199248
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of cyclooxygenase-2 and colorectal adenoma risk: the Self Defense Forces Health Study.
Ueda N; Maehara Y; Tajima O; Tabata S; Wakabayashi K; Kono S
Cancer Sci; 2008 Mar; 99(3):576-81. PubMed ID: 18167131
[TBL] [Abstract][Full Text] [Related]
17. TRPM2 variants and bipolar disorder risk: confirmation in a family-based association study.
Xu C; Li PP; Cooke RG; Parikh SV; Wang K; Kennedy JL; Warsh JJ
Bipolar Disord; 2009 Feb; 11(1):1-10. PubMed ID: 19133961
[TBL] [Abstract][Full Text] [Related]
18. Association study of dopamine receptor genes polymorphism with cognitive functions in bipolar I disorder patients.
Zhao L; Lin Y; Lao G; Wang Y; Guan L; Wei J; Yang Z; Ni P; Li X; Jiang Z; Li T; Hao X; Lin D; Cao L; Ma X
J Affect Disord; 2015 Jan; 170():85-90. PubMed ID: 25233244
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the contribution of cyclooxygenase 2 genotypes to breast cancer in Taiwan.
Su CH; Hsiao CL; Chang WS; Liu LC; Wang HC; Tsai CW; Li LY; Tsai CH; Bau DT
Anticancer Res; 2014 Nov; 34(11):6711-6. PubMed ID: 25368279
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase 2 genetic polymorphism may increase the risk of developing leukoaraiosis in Chinese.
Shan XY; Chen GZ; Cheng GP; Tao HM
J Mol Neurosci; 2013 Oct; 51(2):461-6. PubMed ID: 23852948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
